BIBLIOGRAPHIC RECORD

At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: Findings from a large, prospective, open-label effectiveness trial

This record contains bibliographic metadata. Open the linked source to check the work; the record does not include its full text.

Recorded authors
Thomas D. Hull; Matteo Malgaroli; Adam Gazzaley; Teddy J. Akiki; Alok Madan; Leonardo Vando; Kristin Arden; Jack Swain; Madeline Klotz; Casey Paleos
Source of metadata
OpenAlex
Year recorded
2022

Public identifiers and source

Open the source record

Reference

Thomas D. Hull; Matteo Malgaroli; Adam Gazzaley; Teddy J. Akiki; Alok Madan; Leonardo Vando; Kristin Arden; Jack Swain; Madeline Klotz; Casey Paleos. (2022). At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: Findings from a large, prospective, open-label effectiveness trial. https://openalex.org/W4284896320

Reference assembled from the available metadata. Check and cite the original publication before reusing a claim.

Permanent record URL: https://brain.psiconautica.org/en/documentos/d-3a6bd5bd942c4cc78dbccbf9f2455270/